Implication of mutation of hepatitis C virus 1b “interferon sensitivity determining region” (NS5A aa 2209–2248) response to interferon α therapy in patients with chronic hepatitis C

Abstract

Hepatitis G virus (HCV) isolates from 12 patients with chronic hepatitis C underwent the sequence analysis. Among the 12 patients, 9 obtained a complete response (CR), 2 partial response (PR) and 1 non—response (NR) after the treatment with IFN-α. The results showed that only single amino acide (aa) substitution in iIFN sensitivity determining region (ISDR) (aa 2213 and aa 2218) in 6 cases with CR was observed, while 3 cases of CR and all PR and NR cases had no aa mutation of ISDR. It is suggested that the ISDR in HCV NS5A was yet not identified by our patients.

Keywords

HCV / NS5A / ISDR

References

[1] BlumH. Variants of hepatitis B, C and D viruses: molecular biology and clinical significance. Digestion, 1995, 5685-85

[2] KiyosawaK, TanakaE, SodeyamaT, et al. . Natural history of hepatitis C. Intervirology, 1994, 37101-101

[3] De MitriM, PoussinK, BaccariniP, et al. . HGV-associated liver cancer without cirrhosis. Lancet, 1995, 345431-431

[4] FriedM, HoofnagleJ. Therapy of hepatitis C. Sem Liver Dis, 1995, 1582-82

[5] LinoS, HinoK, YasuduK. Current state of interferon therapy for chronic hepatitis C. Intervirology, 1994, 3787-87

[6] EnomotoN, SakumaI, AsahinaY, et al. . Comparisison of full-length sequences of interferonsensitive and resistant hepatitis C Virus 1b. Sensitivity to interferon is conferred by amino acid substitution in the NS5A region. J Clin Invest, 1995, 96224-224

[7] DavidsonF, SimmondsP, FergusonJ, et al. . Survey of major genotypes and amplified from the 5′ non-cording region. J Gen Virol, 1995, 761197-1197

[8] ZeuzemS, LeeJ, RothW. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and the response to interferon alfa. Hepatoloty, 1997, 25740-740

[9] ChayamaK, TsubotaA, KobayashiM, et al. . Pretreatment virus load and multiple amino acid substitution in the interferon sensitivitydetermining region predict the outcome of interferon treamtment in patients with chronic genotye 1b hepatitis C virus infection. Hepatology, 1997, 25745-745

[10] EnomotoN, SakumaI, AsahinaY, et al. . Mutations in the non-structural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. New England J Med, 1996, 33477-77

[11] KurosakiM, EnomotoN, MurakamiT, et al. . Analysis of genotypes and amino acid residues 2209 to 2248 of the NSA region of the hepatitis C virus infection in relation to the response to interferon beta therapy. Hepatoloty, 1997, 25750-750

[12] KhorsiH, CastelainS, WuseurA, et al. . Mutation of the hepatitis C virus 1b NS5A 2209–2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. J Hepatol, 1997, 27(1): 72-72

[13] SquadritoG, LeoneF, SartoriM, et al. . Mutation in nonstructural 5A region of hepatitis C virus and response of the chronic hepatitis C to interferon alfa. Gastroenterology, 1997, 113567-567

[14] GaleMJ, KorthM, TangN, et al. . Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology, 1997, 23217-217